Latest Updates

EBITDA grew 15.2 per cent in INR Y-o-Y

Alkem will get the exclusive marketing rights for Stempeucel in India for osteoarthritis with stempeutics manufacturing and…

The investment will be utilised to fund the growth and expansion of Strand towards becoming Asia’s leading integrated diagnostics…

The product was manufactured at the drug maker’s Srikakulam plant in Andhra Pradesh Dr Reddy’s Laboratories (DRL) has initiated…

Revenues from operations grew by 11 per cent to Rs 4,336 crore

India revenue swells 15 per cent to Rs 16 bn

Management board meets in an extraordinary session to discuss EMA’s future premises in Amsterdam

The government has invited suggestion/ comment/ objection within 45 days of gazatte notification

The study was a multinational randomised double-blind controlled trial of 52 weeks duration which included more than 500 patients…

Consolidated income from operations also declined to Rs 3,900.36 crore